| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/03/2008 | CA2658362A1 Metalloprotease inhibitors |
| 01/03/2008 | CA2655444A1 New compounds 385 |
| 01/03/2008 | CA2655441A1 New compounds 384 |
| 01/03/2008 | CA2654915A1 Tetrazole-substituted arylamides |
| 01/03/2008 | CA2647601A1 Pyrrole derivatives and their methods of use |
| 01/02/2008 | EP1871769A2 Process for the preparation of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline,their intermediates and crystalline salts thereof |
| 01/02/2008 | EP1871766A1 Antifungal triazole derivatives |
| 01/02/2008 | EP1871762A2 Subtituted heteroaryl cb1 antagonists |
| 01/02/2008 | EP1871758A1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| 01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 01/02/2008 | EP1871741A2 Substituted azetidinones |
| 01/02/2008 | EP1871374A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/02/2008 | EP1282605B1 Thioimidazolidine derivatives as light stabilisers for polymers |
| 01/02/2008 | CN101099286A Method and installation means for installing an electrical machine |
| 01/02/2008 | CN101098865A 1h-indole-3-carboxylic acid derivatives and their use as PPAR agonists |
| 01/02/2008 | CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative |
| 01/02/2008 | CN100358875C Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use |
| 01/02/2008 | CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists |
| 01/01/2008 | USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/01/2008 | US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes. |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 01/01/2008 | US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase |
| 01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 01/01/2008 | US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases |
| 01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
| 01/01/2008 | US7314877 Benzofuran derivative |
| 12/27/2007 | WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition |
| 12/27/2007 | WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 12/27/2007 | WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 12/27/2007 | WO2007148738A1 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof |
| 12/27/2007 | WO2007148676A1 Therapeutic or prophylactic agent for leukemia |
| 12/27/2007 | WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 12/27/2007 | WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 12/27/2007 | WO2007148158A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation |
| 12/27/2007 | WO2007147874A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 12/27/2007 | WO2007147841A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 12/27/2007 | WO2007147778A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 12/27/2007 | WO2007147769A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 12/27/2007 | WO2007147746A1 2-pyrazinecarboxamide derivatives |
| 12/27/2007 | WO2007116230A8 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
| 12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 12/27/2007 | US20070299104 Tetrahydropyranyl Cyclopentyl 1-Substituted and 1,1-Disubstituted Tetrahydroisoquinoline Modulators of Chemokine Receptor Activity |
| 12/27/2007 | US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299069 Methods for treating hepatitis C |
| 12/27/2007 | US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity |
| 12/27/2007 | US20070299065 Tetrahydropyran Derivatives as Antidiabetics |
| 12/27/2007 | US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/27/2007 | US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers |
| 12/27/2007 | US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 12/27/2007 | US20070299056 Benzazepine derivatives for the treatment of neurological disorders |
| 12/27/2007 | US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 12/27/2007 | DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections |
| 12/27/2007 | CA2657213A1 Peptide epoxyketones for proteasome inhibition |
| 12/27/2007 | CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof |
| 12/27/2007 | CA2655801A1 Therapeutic or prophylactic agent for leukemia |
| 12/27/2007 | CA2655789A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation |
| 12/27/2007 | CA2655573A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 12/27/2007 | CA2654781A1 2-pyrazinecarboxamide derivatives |
| 12/27/2007 | CA2654689A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 12/27/2007 | CA2654358A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 12/26/2007 | EP1870409A1 Benzimidazole compound |
| 12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
| 12/26/2007 | EP1869040A1 Dna-pk inhibitors |
| 12/26/2007 | EP1869022A1 Naphthalamide derivatives having antiproliferative activity |
| 12/26/2007 | EP1869021A1 Dna-pk inhibitors |
| 12/26/2007 | EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 12/26/2007 | EP1869003A1 Indazoles as glucocorticoid receptor ligands |
| 12/26/2007 | EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 12/26/2007 | EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 12/26/2007 | EP1556390A4 Functionalized ionic liquids, and methods of use thereof |
| 12/26/2007 | EP1539708B1 Benzimidazolones and their use as cytokine inhibitors |
| 12/26/2007 | EP1233769B1 Imidazole derivatives |
| 12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 12/26/2007 | CN101094861A Agonists and antagonists of the somatostatin receptor |
| 12/26/2007 | CN101094848A Organic compounds |
| 12/26/2007 | CN101094846A 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 12/26/2007 | CN101094836A Methods for preparing indazole compounds |
| 12/26/2007 | CN101092415A Compound of new benzo heterocycle categories, preparation method and application |
| 12/26/2007 | CN101092414A Preparation and application of a category of 6 ¿C aryl ¿C 3 ¿C cycroamido methyl pyrone derviation |
| 12/26/2007 | CN101092384A A category of compound of alpha ¿C amido - N ¿C substituent amide, its composition, and application |
| 12/26/2007 | CN100357290C Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles |
| 12/26/2007 | CN100357289C Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 12/26/2007 | CN100357278C Substituted triazole diamine derivatives as kinase inhibitors |
| 12/26/2007 | CN100357277C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100357273C Process for the production of substituted nicotinic acid esters |
| 12/26/2007 | CN100357270C D-proline derivative |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/25/2007 | US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically |
| 12/25/2007 | US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast |
| 12/25/2007 | US7312235 Anticoagulants |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis |